ID Analysts

Our seasoned team of analysts continually monitors investment opportunities around the world, to provide investors with the widest possible array of money-making ideas.

Analyst Articles

Medicine Man Technologies (OTC: MDCL) belongs to a fast-growing marijuana industry niche: consulting and infrastructure services. Medicine Man is not a marijuana producer. The chattering class on Wall Street is infatuated with cannabis stocks. But with Medicine Man, we must raise several caveats. Not only is this a marijuana play,… Read More

If you bought a stock option, it could be “in the money.” But what does that mean? It means that, for the moment, the underlying stock has moved beyond the option’s strike price. There’s a lot to unpack in that last sentence. I’ll do so in this guide. The Strike… Read More

If you bought a stock option, it could be “out of the money.” But what, exactly, is “out of the money”? It means that, for the moment, the underlying stock has yet to move beyond the option’s strike price. There’s a lot going on in that last sentence. I’ll break… Read More

When it comes to choosing an online broker, there are countless choices. But are some of them better for options trading than others? In a word: yes. For starters, you need to pay attention to commission costs. If you pick a broker that charges a high fee for trades, any… Read More

If you’re serious about making money with options, then you might be asking yourself: “What is the cheapest brokerage for options trading?” First of all: congratulations. It’s a very good that you’re even asking that question. Trading options can get very expensive with the wrong broker. That’s especially the case… Read More

This article will examine a popular topic for many investors: the cheapest blue chip stocks. Blue chips stocks are often considered core holdings in long-term diversified portfolios. The general idea is that these are legacy companies that are “quality investments”, leaders in their field, and have massive market capitalizations. Most… Read More